Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Browse
News
Browse
Subscribe

Conference News

SABCS 2019: Breast biopsies after neoadjuvant chemotherapy accurately predict presence of residual breast cancer

(17 Dec 2019)

SABCS 2019: Patient-reported outcomes predict aromatase inhibitor adherence

(16 Dec 2019)

SABCS 2019: Oral paclitaxel yielded better outcomes than intravenous paclitaxel for metastatic breast cancer patients in phase III trial

(13 Dec 2019)

SABCS 2019: Residual cancer burden can predict outcomes for patients with any breast cancer type

(13 Dec 2019)

SABCS 2019: Long-term follow-up shows oestrogen alone and oestrogen plus progestin have opposite effects on breast cancer incidence in postmenopausal women

(13 Dec 2019)

SABCS 2019: Circulating tumour DNA may help predict recurrence in patients with early triple-negative breast cancer

(13 Dec 2019)

SABCS 2019: Extended letrozole therapy improves disease-free survival in postmenopausal women with HR-positive breast cancer

(13 Dec 2019)

SABCS 2019: MINDACT trial data reveal certain women with luminal breast cancer may be undertreated with tamoxifen alone

(13 Dec 2019)

SABCS 2019: Partial breast irradiation may be as effective as whole breast irradiation in preventing recurrence in patients with early breast cancer

(12 Dec 2019)

SABCS 2019: Adding tucatinib to drug combination extends survival for advanced HER2-positive breast cancer patients

(12 Dec 2019)

View all articles from the past year >

follow us

Biosimilar Medicines Core Principles and Communication


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation